OnCore Login

Return to Trial Database

HCRN-LUN91-2

A Phase II Trial of CODE + G-CSF in Advanced NSCL

Status

Study Completed

Cancer Type(s)

Lung

Study Contact

Publications

A Phase II Hoosier Oncology Group Trial using CODE Chemotherapy in Patients with Unresectable Stage III or IV Non-Small Cell Lung Cancer (NSCLC)
  • A Sandler, C Nichols, S Rynard, R Ansari, C Blanke, L Einhorn
A Phase II Trial of CODE (Cisplatin, Vincristine, Doxorubicin, Etoposide) Plus Granulocyte-Colony Stimulating Factor (G-CSF) in Advanced Non-Small Cell Lung Cancer
  • A Sandler, C Blanke, F Monaco, MA Carey, R Ansari, B Fisher, CH Spiridonidis, L Einhorn, C Nichols

Trial Locations

All sites in which the trial HCRN-LUN91-2 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278